377 related articles for article (PubMed ID: 27659477)
21. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.
Axelsson Raja A; Farhad H; Valente AM; Couce JP; Jefferies JL; Bundgaard H; Zahka K; Lever H; Murphy AM; Ashley E; Day SM; Sherrid MV; Shi L; Bluemke DA; Canter CE; Colan SD; Ho CY
Circulation; 2018 Aug; 138(8):782-792. PubMed ID: 29622585
[TBL] [Abstract][Full Text] [Related]
22. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
[TBL] [Abstract][Full Text] [Related]
23. Patterns of CMR measured longitudinal strain and its association with late gadolinium enhancement in patients with cardiac amyloidosis and its mimics.
Williams LK; Forero JF; Popovic ZB; Phelan D; Delgado D; Rakowski H; Wintersperger BJ; Thavendiranathan P
J Cardiovasc Magn Reson; 2017 Aug; 19(1):61. PubMed ID: 28784140
[TBL] [Abstract][Full Text] [Related]
24. The Significance of Interstitial Fibrosis on Left Ventricular Function in Hypertensive versus Hypertrophic Cardiomyopathy.
Jiang M; Wang Z; Su X; Gong X; Pu J; Wu L; Liu C; Yao Q; Kong L; Xu J; He B
Sci Rep; 2018 Jul; 8(1):9995. PubMed ID: 29968754
[TBL] [Abstract][Full Text] [Related]
25. Myocardial fibrosis evaluated by diffusion-weighted imaging and its relationship to 3D contractile function in patients with hypertrophic cardiomyopathy.
Wu R; An DA; Shi RY; Chen BH; Jiang M; Bacyinski A; Han TT; Hu J; Xu JR; Wu LM
J Magn Reson Imaging; 2018 Oct; 48(4):1139-1146. PubMed ID: 29601139
[TBL] [Abstract][Full Text] [Related]
26. Radiomic Analysis of Myocardial Native T
Neisius U; El-Rewaidy H; Nakamori S; Rodriguez J; Manning WJ; Nezafat R
JACC Cardiovasc Imaging; 2019 Oct; 12(10):1946-1954. PubMed ID: 30660549
[TBL] [Abstract][Full Text] [Related]
27. In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.
Brouwer WP; Baars EN; Germans T; de Boer K; Beek AM; van der Velden J; van Rossum AC; Hofman MB
J Cardiovasc Magn Reson; 2014 Apr; 16(1):28. PubMed ID: 24766828
[TBL] [Abstract][Full Text] [Related]
28. Association between myocardial hypoxia and fibrosis in hypertrophic cardiomyopathy: analysis by T2* BOLD and T1 mapping MRI.
Ando K; Nagao M; Watanabe E; Sakai A; Suzuki A; Nakao R; Ishizaki U; Sakai S; Hagiwara N
Eur Radiol; 2020 Aug; 30(8):4327-4336. PubMed ID: 32211964
[TBL] [Abstract][Full Text] [Related]
29. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
[TBL] [Abstract][Full Text] [Related]
30. The Value of Myocardial Fibrosis Parameters Derived from Cardiac Magnetic Resonance Imaging in Risk Stratification for Patients with Hypertrophic Cardiomyopathy.
Yu T; Cai Z; Yang Z; Lin W; Su Y; Li J; Xie S; Shen J
Acad Radiol; 2023 Sep; 30(9):1962-1978. PubMed ID: 36604228
[TBL] [Abstract][Full Text] [Related]
31. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1.
Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB
JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587
[TBL] [Abstract][Full Text] [Related]
32. Left-ventricular mechanics in children with hypertrophic cardiomyopathy. CMR study.
Mazurkiewicz Ł; Ziółkowska L; Petryka J; Śpiewak M; Małek Ł; Kubik A; Marczak M; Misko J; Brzezińska-Rajszys G
Magn Reson Imaging; 2017 Nov; 43():56-65. PubMed ID: 28688952
[TBL] [Abstract][Full Text] [Related]
33. Use of Myocardial T1 Mapping at 3.0 T to Differentiate Anderson-Fabry Disease from Hypertrophic Cardiomyopathy.
Karur GR; Robison S; Iwanochko RM; Morel CF; Crean AM; Thavendiranathan P; Nguyen ET; Mathur S; Wasim S; Hanneman K
Radiology; 2018 Aug; 288(2):398-406. PubMed ID: 29688154
[TBL] [Abstract][Full Text] [Related]
34. 4D flow MRI and T1 -Mapping: Assessment of altered cardiac hemodynamics and extracellular volume fraction in hypertrophic cardiomyopathy.
van Ooij P; Allen BD; Contaldi C; Garcia J; Collins J; Carr J; Choudhury L; Bonow RO; Barker AJ; Markl M
J Magn Reson Imaging; 2016 Jan; 43(1):107-14. PubMed ID: 26227419
[TBL] [Abstract][Full Text] [Related]
35. Tissue characterisation and myocardial mechanics using cardiac MRI in children with hypertrophic cardiomyopathy.
Sunthankar S; Parra DA; George-Durrett K; Crum K; Chew JD; Christensen J; Raucci FJ; Xu M; Slaughter JC; Soslow JH
Cardiol Young; 2019 Dec; 29(12):1459-1467. PubMed ID: 31769372
[TBL] [Abstract][Full Text] [Related]
36. Electrocardiography based prediction of hypertrophy pattern and fibrosis amount in hypertrophic cardiomyopathy: comparative study with cardiac magnetic resonance imaging.
Park CH; Chung H; Kim Y; Kim JY; Min PK; Lee KA; Yoon YW; Kim TH; Lee BK; Hong BK; Rim SJ; Kwon HM; Choi EY
Int J Cardiovasc Imaging; 2018 Oct; 34(10):1619-1628. PubMed ID: 29728953
[TBL] [Abstract][Full Text] [Related]
37. Native T1 mapping and extracellular volume fraction for differentiation of myocardial diseases from normal CMR controls in routine clinical practice.
Thongsongsang R; Songsangjinda T; Tanapibunpon P; Krittayaphong R
BMC Cardiovasc Disord; 2021 Jun; 21(1):270. PubMed ID: 34082703
[TBL] [Abstract][Full Text] [Related]
38. Ultrasonic Assessment of Myocardial Microstructure in Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers With and Without Left Ventricular Hypertrophy.
Hiremath P; Lawler PR; Ho JE; Correia AW; Abbasi SA; Kwong RY; Jerosch-Herold M; Ho CY; Cheng S
Circ Heart Fail; 2016 Sep; 9(9):. PubMed ID: 27623770
[TBL] [Abstract][Full Text] [Related]
39. Native T1-mapping for non-contrast assessment of myocardial fibrosis in patients with hypertrophic cardiomyopathy--comparison with late enhancement quantification.
Małek ŁA; Werys K; Kłopotowski M; Śpiewak M; Miłosz-Wieczorek B; Mazurkiewicz Ł; Petryka-Mazurkiewicz J; Marczak M; Witkowski A
Magn Reson Imaging; 2015 Jul; 33(6):718-24. PubMed ID: 25863138
[TBL] [Abstract][Full Text] [Related]
40. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.
Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM
Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]